Triaj is a professional services organization that provides premier biotechnology services worldwide. We review potential investments and acquisition targets for, and provide general scientific advice to, venture capital, investment and legal communities. We also provide a wide range of scientific consulting services to the pharmaceutical and biotechnology industry in the areas of gene mapping, functional genomics, proteomics, diagnostics, bioinformatics, genetic statistics, genetic epidemiology, and gene targeted therapeutics.

In 2000, over $35 billion was raised in all forms of financing - over three times more than any previous year, with venture capital investment more than doubled to $5.7 billion. The rate of investment, merger activity, new business startup and new product development in biotechnology is growing rapidly, fueling similarly strong demand growth in biotechnology advisory services.

Although investment activity is strong and rapidly expanding, there is a scarcity of scientific expertise to evaluate and manage technical information. There is an acute shortage of skilled and experienced scientists available to meet the growing demand of the pharmaceutical and biotechnology industry and provide specialized expertise on projects.

Triaj has contracted a team of leading scientists and researchers around the world, providing a depth of experience and intellectual resources, and a breadth of discipline coverage, that is not available from any other source. Our outstanding mix of scientific expertise uniquely positions Triaj to meet the growing demand for biotechnology consulting services in the investment community and in the biotechnology and pharmaceutical industries.